AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

OTCMKTS:INVVYINDIVIOR PLC/S Competitors & Alternatives

$4.90
+0.53 (+12.13 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.82
Now: $4.90
$6.10
50-Day Range
$2.80
MA: $4.53
$11.20
52-Week Range
$2.23
Now: $4.90
$40.00
Volume76,789 shs
Average Volume126,444 shs
Market Capitalization$717.79 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3

Competitors

INDIVIOR PLC/S (OTCMKTS:INVVY) Competitors and Alternatives

The following companies in the "pharmaceutical preparations" industry are considered alternatives and competitors to INDIVIOR PLC/S.

Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)
Uniqure logo
QURE
Uniqure
1.5$58.87+4.2%$2.78 billion$7.28 million-19.56
Axsome Therapeutics logo
AXSM
Axsome Therapeutics
1.6$77.38+3.7%$2.76 billionN/A-30.23
Alkermes logo
ALKS
Alkermes
1.5$17.19+2.1%$2.65 billion$1.17 billion-19.53Analyst Downgrade
Insmed logo
INSM
Insmed
1.5$25.83+5.0%$2.61 billion$136.47 million-9.16Analyst Downgrade
Taro Pharmaceutical Industries logo
TARO
Taro Pharmaceutical Industries
1.4$68.03+0.4%$2.61 billion$644.77 million10.70Analyst Downgrade
Amarin logo
AMRN
Amarin
1.8$6.68+1.2%$2.61 billion$429.76 million-111.33Analyst Report
Analyst Revision
KRTX
Karuna Therapeutics
1.5$97.59+0.0%$2.55 billionN/A-0.66Analyst Report
Insider Selling
Analyst Revision
Heavy News Reporting
Intercept Pharmaceuticals logo
ICPT
Intercept Pharmaceuticals
1.8$77.92+2.0%$2.53 billion$252 million-7.27Analyst Report
TPTX
Turning Point Therapeutics
1.4$62.18+12.9%$2.52 billionN/A-17.27
Apellis Pharmaceuticals logo
APLS
Apellis Pharmaceuticals
1.7$31.44+2.0%$2.50 billionN/A-5.01Analyst Downgrade
Heavy News Reporting
Ra Pharmaceuticals logo
RARX
Ra Pharmaceuticals
0.7$47.99+0.0%$2.27 billion$3 million-20.77
TG Therapeutics logo
TGTX
TG Therapeutics
1.7$18.28+3.8%$2.09 billion$150,000.00-9.00Analyst Report
Prestige Consumer Healthcare logo
PBH
Prestige Consumer Healthcare
1.7$41.02+1.0%$2.08 billion$963.01 million14.76
Principia Biopharma logo
PRNB
Principia Biopharma
1.4$60.12+4.2%$2.07 billion$35.16 million-24.64
Pacira Biosciences logo
PCRX
Pacira Biosciences
1.6$48.55+3.4%$2.04 billion$421.03 million-2,426.29
Ligand Pharmaceuticals logo
LGND
Ligand Pharmaceuticals
1.4$122.00+1.7%$1.92 billion$120.28 million-35.47Analyst Upgrade
Insider Selling
Heavy News Reporting
Eidos Therapeutics logo
EIDX
Eidos Therapeutics
1.1$49.06+1.0%$1.91 billion$26.69 million-37.17Analyst Upgrade
IGMS
IGM Biosciences
1.2$58.40+6.8%$1.91 billionN/A-12.17
SAGE Therapeutics logo
SAGE
SAGE Therapeutics
1.6$36.21+2.9%$1.87 billion$6.87 million-2.91Analyst Downgrade
ZNTL
Passage Bio
1.8$48.49+4.8%$1.82 billionN/A0.00
Epizyme logo
EPZM
Epizyme
1.6$17.11+1.9%$1.76 billion$23.80 million-8.43Analyst Downgrade
Zymeworks logo
ZYME
Zymeworks
2.1$36.60+1.1%$1.75 billion$29.54 million-9.41Analyst Report
Unusual Options Activity
Madrigal Pharmaceuticals logo
MDGL
Madrigal Pharmaceuticals
1.8$112.65+1.8%$1.73 billionN/A-16.54Analyst Report
Aurinia Pharmaceuticals logo
AUPH
Aurinia Pharmaceuticals
1.8$14.94+1.1%$1.73 billion$320,000.00-11.40Analyst Downgrade
Heron Therapeutics logo
HRTX
Heron Therapeutics
1.4$19.28+4.4%$1.71 billion$145.97 million-8.49Unusual Options Activity
Heavy News Reporting
Xencor logo
XNCR
Xencor
1.4$30.01+0.5%$1.70 billion$156.70 million-28.04
Zogenix logo
ZGNX
Zogenix
2.0$29.97+1.8%$1.68 billion$3.65 million-3.17
Theravance Biopharma logo
TBPH
Theravance Biopharma
1.5$26.30+1.3%$1.68 billion$73.41 million-6.06
Y-mAbs Therapeutics logo
YMAB
Y-mAbs Therapeutics
1.5$43.04+3.2%$1.68 billionN/A-17.29Insider Selling
Corcept Therapeutics logo
CORT
Corcept Therapeutics
1.5$14.19+0.5%$1.63 billion$306.49 million16.13Analyst Downgrade
Ironwood Pharmaceuticals logo
IRWD
Ironwood Pharmaceuticals
1.4$9.79+2.7%$1.60 billion$428.41 million18.47
Opko Health logo
OPK
Opko Health
2.3$2.35+3.4%$1.59 billion$901.90 million-4.90Insider Buying
Constellation Pharmaceuticals logo
CNST
Constellation Pharmaceuticals
1.6$37.39+0.3%$1.58 billionN/A-12.80Analyst Upgrade
Akebia Therapeutics logo
AKBA
Akebia Therapeutics
1.7$11.96+1.8%$1.58 billion$335 million-5.41
BLUSF
BELLUS Health
0.5N/AN/A$1.52 billion$30,000.000.00High Trading Volume
Dicerna Pharmaceuticals logo
DRNA
Dicerna Pharmaceuticals
1.7$20.27+3.5%$1.50 billion$23.90 million-11.99Analyst Downgrade
Insider Selling
Akcea Therapeutics logo
AKCA
Akcea Therapeutics
1.2$15.24+2.9%$1.50 billion$488.54 million-50.80
IMAB
I-Mab
1.0$23.86+8.1%$1.47 billion$4.31 million-0.83
CytoDyn logo
CYDY
CytoDyn
1.3$2.85+2.1%$1.47 billionN/A-13.57Analyst Upgrade
ZEALAND PHARMA/S logo
ZEAL
ZEALAND PHARMA/S
0.8$36.86+7.3%$1.44 billion$6.20 million-13.65
Arcus Biosciences logo
RCUS
Arcus Biosciences
1.5$29.05+3.4%$1.44 billion$15 million-13.45Analyst Report
Analyst Revision
Innoviva logo
INVA
Innoviva
1.5$13.90+0.4%$1.43 billion$261.02 million8.13Analyst Downgrade
Amneal Pharmaceuticals logo
AMRX
Amneal Pharmaceuticals
2.4$4.67+2.6%$1.43 billion$1.63 billion-2.90
Myovant Sciences logo
MYOV
Myovant Sciences
1.9$16.12+1.9%$1.42 billionN/A-4.78Analyst Report
Portola Pharmaceuticals logo
PTLA
Portola Pharmaceuticals
1.5$17.91+0.1%$1.41 billion$116.64 million-4.75
Intra-Cellular Therapies logo
ITCI
Intra-Cellular Therapies
1.5$21.59+1.0%$1.38 billion$60,000.00-7.77
ARVN
Arvinas
1.6$35.58+7.6%$1.31 billion$42.98 million-16.10Analyst Downgrade
Karyopharm Therapeutics logo
KPTI
Karyopharm Therapeutics
1.8$17.73+0.4%$1.30 billion$40.89 million-6.07Analyst Downgrade
Tricida logo
TCDA
Tricida
2.2$26.10+0.4%$1.30 billionN/A-6.07
ARQT
I-Mab
1.6$31.43+3.0%$1.28 billionN/A0.00
This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.